Mako Surgical’s shareholders approve Stryker Corp.’s $1.65 billion acquisition bid.
Mako Surgical (NSDQ:MAKO) cleared a hurdle on the way to its $1.65 billion buyout by Stryker (NYSE:SYK) when its shareholders approved the acquisition last week.
About 65% of the robotic surgery company’s shareholders voted on the $30-per-share deal, with 99% voting to approve the transaction, according to a press release. The stock owners also gave their non-binding OK for “specified compensation payable to the company’s named executive officers in connection with the merger,” Mako said.
The deal is expected to close tomorrow, according to the release.
